Paola Valentino | Biomarkers | Best Researcher Award

Posted on by Pencis

Dr. Paola Valentino | Biomarkers | Best Researcher Award

šŸ”¬ Dr. Paola Valentino, a trailblazing leader in biomarkers at the University of Turin, spearheads groundbreaking initiatives in translational research. šŸŒ As the driving force behind the establishment of the Department’s biobank, she expertly manages cryogenic facilities, informed consent procedures, and sample/data documentation. Her extensive research fellowship at the Neuroscience Institute focused on Multiple Sclerosis and NMOSD, delving into biomarkers like Neurofilament Light Chain and anti-aquaporin 4 antibodies. šŸ§Ŗ Dr. Valentino excels in quality management, shaping the CRESM Biobank’s protocols and legal documents while actively contributing to national and international biobanking initiatives. šŸŒ Her rich background, spanning from gene expression analysis to board certification in clinical and analytical biochemistry, showcases her multidisciplinary prowess. šŸŽ“ Fluent in Italian, with proficiency in English and French, Dr. Valentino is a dynamic force in the intersection of science, ethics, and biobanking standards. šŸŒŸ

Profile:

Scopus

Orcid

Education:

šŸ‘©ā€šŸŽ“ Dr. Paola Valentino, a Turin native, embarked on her academic journey with a Bachelor’s degree in Medical Biotechnology (L1) from the University of Turin in 2003. šŸŽ“ Her commitment to excellence continued as she earned a Master’s degree in Medical Biotechnology (9/S) on 23/07/2003, solidifying her expertise in the field. šŸ§Ŗ Driven by a passion for analytical biochemistry, she achieved Board Certification in Clinical and Analytical Biochemistry from the University of Turin on 27/07/2005. šŸ† These educational milestones laid the foundation for her remarkable career as a leader in biomarker research and biobanking. šŸŒŸ

Experience:

šŸŒŸ Dr. Paola Valentino is a dynamic force in the world of biomarkers, currently serving as Technical Administrative Personnel at the University of Turin since 03/07/2023. šŸ›ļø Her impactful role involves establishing the biobank for the Department of Clinical and Biological Sciences, overseeing cryogenic facilities, documentation, informed consent, and managing samples and data. šŸ§Ŗ Concurrently, she engages in cutting-edge translational research activities, focusing on biomarkers.

šŸ”¬ Prior to her current position, Dr. Valentino held a significant role at the Neuroscience Institute Cavalieri Ottolenghi (NICO)/University Hospital San Luigi Gonzaga from 18/09/2006 to 30/06/2023. During this tenure, her research spanned multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD). Notably, she pioneered studies on Neurofilament Light Chain as a biomarker, validated methods for anti-aquaporin 4 antibodies, and explored the diagnostic potential of anti-potassium channel KIR4.1 antibodies.

šŸŒ Dr. Valentino’s impact extends to quality management in the CRESM biobank since 08/04/2021, where she defines sample collection protocols, updates databases, implements biobank software, and ensures compliance with ethical and legal standards, including GDPR. šŸŒ Her diverse expertise also includes participating in international biobanking working groups, contributing to standards like UNI ISO 20387, and collaborating on gene expression analysis with the Italian Foundation for Multiple Sclerosis. šŸ¤ Dr. Valentino’s multifaceted contributions solidify her as a key figure in the intersection of research, biobanking, and quality management.

Publication:

  • Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder
    • Author: Carta, S., Dinoto, A., Capobianco, M., … Marignier, R., Mariotto, S.
    • Year: 2024
    • Journal: Neurology(R) Neuroimmunology & Neuroinflammation, 11(1), pp. e200188
  • Ocrelizumab Extended Interval Dosing in Primary Progressive Multiple Sclerosis: An Italian Experience
    • Authors: ZanghƬ, A., Ferraro, D., Callari, G., … Avolio, C., Dā€™amico, E.
    • Year: 2024
    • Journal: Current Neuropharmacology, 22(2), pp. 339ā€“345
  • Cerebrospinal fluid neurofilament light chains predict early disease activity in Multiple Sclerosis
    • Authors: Toscano, S., Oteri, V., Chisari, C.G., … Zappia, M., Patti, F.
    • Year: 2023
    • Journal: Multiple Sclerosis and Related Disorders, 80, 105131
  • Correction to: Daytime sleepiness and sleep quality in Charcotā€“Marieā€“Tooth disease (Journal of Neurology)
    • Authors: Bellofatto, M., Gentile, L., Bertini, A., … Iabichella, G., Barone, S.
    • Year: 2023
    • Journal: Journal of Neurology, 270(11), pp. 5569ā€“5570
  • Daytime sleepiness and sleep quality in Charcotā€“Marieā€“Tooth disease
    • Authors: Bellofatto, M., Gentile, L., Bertini, A., … Iabichella, G., Barone, S.
    • Year: 2023
    • Journal: Journal of Neurology, 270(11), pp. 5561ā€“5568
  • Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register
    • Authors: Mosconi, P., Guerra, T., Paletta, P., … Zaffaroni, M., Zarbo, R.
    • Year: 2023
    • Journal: Neurological Sciences, 44(11), pp. 4001ā€“4011
  • Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients
    • Authors: Valentino, P., Malucchi, S., Bava, C.I., … Di Sapio, A., Bertolotto, A.
    • Year: 2023
    • Journal: Multiple Sclerosis and Related Disorders, 77, 104893
  • Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey
    • Authors: Altieri, M., Capuano, R., Bisecco, A., … Tedeschi, G., Gallo, A.
    • Year: 2023
    • Journal: Multiple Sclerosis and Related Disorders, 77, 104870
  • The one-and-a-half syndrome: a distinctive clinical finding in a patient with multiple sclerosis
    • Authors: Fratto, E., Barone, S., Tinelli, E., … Gambardella, A., Valentino, P.
    • Year: 2023
    • Journal: Neurological Sciences, 44(9), pp. 3331ā€“3333
  • Clinical spectrum and frequency of Charcotā€“Marieā€“Tooth disease in Italy: Data from the National CMT Registry
    • Authors: Pisciotta, C., Bertini, A., Tramacere, I., … Vita, G., Pareyson, D.
    • Year: 2023
    • Journal: European Journal of Neurology, 30(8), pp. 2461ā€“2470

 

 

Aylin Aydin Sayilan | Anxiety disorders | Best Researcher Award

Posted on by Pencis

Assoc Prof DrĀ Aylin Aydin Sayilan:Ā Anxiety disorders |Ā Best Researcher Award

ASSOC.PROF. ATĀ Ā KIRKLARELI UNIVERSITY, TURKEY

Aylin Aydın Sayılan is an Associate Professor at the Nursing Department of the Faculty of Health Sciences at Kırklareli University. She submitted her application for the 2022 Academic Incentive with an impressive record of academic achievements. Her expertise lies in Surgical Diseases Nursing, particularly in the management of pain through non-pharmacological interventions. In her application, she listed various academic activities, including 33 publications, with notable contributions such as “Ağrı Yƶnetiminde Ä°laƧ Dışı Uygulamalar” and “The Relationship between the Use of Complementary and Alternative Medicine in Cardiovascular Diseases with Self-Care Ability and Life Quality.”

Publication Profile

šŸ“… Recent Achievements:

Co-authored a study on the relationship between fluids consumed by surgical patients and their gastrointestinal motility. Explored the connection between kinesiophobia, functional level, mobility, and pain in older adults after surgery.

šŸ† Recognition: Received notable attention with a total academic activity score of 96.42 and a net score of 60.00 in the 2022 academic teşvik application.

šŸ“š Publications:

Co-authored the book “Ağrı Yƶnetiminde Ä°laƧ Dışı Uygulamalar” (Non-Drug Applications in Pain Management), contributing to chapters on the impact of pain on life quality. Published articles in international journals on topics ranging from the relationship between complementary medicine and cardiovascular diseases to the effects of COVID-19 fear on attitudes toward cancer screening.

Research Focus:

Aydın Sayılan’s research focuses on diverse aspects of healthcare, spanning from the psychological well-being of patients undergoing medical procedures, such as precolonoscopy lavender inhalation and long-term lavender administration during hemodialysis, to the professional values and job stress experienced by surgical nurses. Additionally, Aydın explores the impact of surgical interventions, like transurethral resection of the prostate, on the quality of life for patient spouses. The systematic review and meta-analysis on the effect of lavender oil on preoperative anxiety showcase an interest in complementary therapies. Furthermore, the investigation into the agreement between nurses’ mental health and compliance with isolation measures during the COVID-19 pandemic reflects a timely exploration of contemporary healthcare challenges.

 

Publications Top Notes

The Effect of Precolonoscopy Lavender Inhalation on Patient Anxiety and Comfort: A Randomized, Controlled, Double-Blinded, Single-Center Study

Effects of Long-term Administration of Inhaled Lavender During Hemodialysis on Patients’ Invasive Pain, Anxiety, and Comfort During Cannulation: A Single-blind Randomized Controlled Trial

An Investigation of Surgical Nurses’ Professional Values, Ethical Sensitivity and Quality of Care: A Cross-Sectional Study From Northwest Turkey

Examining the Job Stress Experienced by Surgical Nurses and Their Psychological Resilience Status

The effect of transurethral resection of the prostate on sexual life quality in patient spouses